Clinical Trial Update: RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy [NA]

View source ↗

Summary

RAMYD Study completed evaluating arrhythmic risk in patients with Myotonic Dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Myotonic Dystrophy, Sudden Cardiac Death | NA | Status: COMPLETED